These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38779109)

  • 21. A Comparative Study of Hemorrhagic Conversion Patterns After Stroke Thrombolysis With Alteplase Versus Tenecteplase.
    Ezzeldin M; Hill C; Kerro A; Percenti E; Delora A; Santos J; Saei H; Greco L; Ezzeldin R; El-Ghanem M; Alderazi Y; Kim Y; Poitevint C; Mir O
    Cureus; 2023 Oct; 15(10):e46889. PubMed ID: 37859677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality of Life After Intravenous Thrombolysis for Acute Ischemic Stroke: Results From the AcT Randomized Controlled Trial.
    Sajobi TT; Arimoro OI; Ademola A; Singh N; Bala F; Almekhlafi MA; Deschaintre Y; Coutts SB; Thirunavukkarasu S; Khosravani H; Appireddy R; Moreau F; Gubitz GJ; Tkach A; Catanese L; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar JS; Williams H; Field TS; Manosalva A; Siddiqui M; Zafar A; Imoukhuede O; Hunter G; Demchuk AM; Mishra SM; Gioia LC; Jalini S; Cayer C; Phillips SJ; Elamin E; Shoamanesh A; Subramaniam S; Kate MP; Jacquin G; Camden MC; Benali F; Alhabli I; Horn M; Stotts G; Hill MD; Gladstone DJ; Poppe AY; Sehgal A; Zhang Q; Lethebe B; Doram C; Shamy M; Kenney C; Buck BH; Swartz RH; Menon BK
    Stroke; 2024 Mar; 55(3):524-531. PubMed ID: 38275116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early Recanalization Among Patients Undergoing Bridging Therapy With Tenecteplase or Alteplase.
    Checkouri T; Gerschenfeld G; Seners P; Yger M; Ben Hassen W; Chausson N; Olindo S; Caroff J; Marnat G; Clarençon F; Baron JC; Turc G; Alamowitch S;
    Stroke; 2023 Oct; 54(10):2491-2499. PubMed ID: 37622385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tenecteplase use in the management of acute ischemic stroke: Literature review and clinical considerations.
    Hailu K; Cannon C; Hayes S
    Am J Health Syst Pharm; 2022 Jun; 79(12):944-949. PubMed ID: 35020806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tenecteplase and Alteplase for Thrombolysis of Acute Ischemic Stroke within 4.5 Hours: An Efficacy and Safety Study.
    Dhar N; Kumar M; Tiwari A; Desai I; Madhaw G; Kumar N
    Ann Indian Acad Neurol; 2022; 25(5):897-901. PubMed ID: 36561006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Time to Thrombolysis With Early Reperfusion After Alteplase and Tenecteplase in Patients With Large Vessel Occlusion.
    Yogendrakumar V; Beharry J; Churilov L; Pesavento L; Alidin K; Ugalde M; Weir L; Mitchell PJ; Kleinig TJ; Yassi N; Thijs VN; Wu TY; Brown H; Dewey HM; Wijeratne T; Yan B; Sharma GJ; Desmond P; Parsons MW; Donnan GA; Davis SM; Campbell BCV;
    Neurology; 2024 Apr; 102(7):e209166. PubMed ID: 38502892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-world comparative safety and efficacy of tenecteplase
    Psychogios K; Palaiodimou L; Katsanos AH; Magoufis G; Safouris A; Kargiotis O; Spiliopoulos S; Papageorgiou E; Theodorou A; Voumvourakis K; Broutzos E; Stamboulis E; Tsivgoulis G
    Ther Adv Neurol Disord; 2021; 14():1756286420986727. PubMed ID: 33488774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke.
    Parsons M; Spratt N; Bivard A; Campbell B; Chung K; Miteff F; O'Brien B; Bladin C; McElduff P; Allen C; Bateman G; Donnan G; Davis S; Levi C
    N Engl J Med; 2012 Mar; 366(12):1099-107. PubMed ID: 22435369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous Thrombolysis With Tenecteplase in Patients With Large Vessel Occlusions: Systematic Review and Meta-Analysis.
    Katsanos AH; Safouris A; Sarraj A; Magoufis G; Leker RR; Khatri P; Cordonnier C; Leys D; Shoamanesh A; Ahmed N; Alexandrov AV; Tsivgoulis G
    Stroke; 2021 Jan; 52(1):308-312. PubMed ID: 33272127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of tenecteplase versus alteplase for acute ischemic stroke.
    Nguyen CP; Lahr MM; van der Zee DJ; van Voorst H; Roos YB; Uyttenboogaart M; Buskens E
    Eur Stroke J; 2023 Sep; 8(3):638-646. PubMed ID: 37641549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative safety of tenecteplase vs alteplase for acute ischemic stroke.
    Flint AC; Eaton A; Melles RB; Hartman J; Cullen SP; Chan SL; Rao VA; Nguyen-Huynh MN; Kapadia B; Patel NU; Klingman JG
    J Stroke Cerebrovasc Dis; 2024 Jan; 33(1):107468. PubMed ID: 38039801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A practice game changer: Impact of tenecteplase for acute ischemic stroke in a multicenter quality improvement project.
    Noh L; Pham F; Haddad L; Burkhard T; Paletz L; Pech M; Lewis M; Manoukian V; Schlick KH; Song S
    Am J Health Syst Pharm; 2022 Apr; 79(9):e149-e153. PubMed ID: 35037028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of thrombolytic agents in treatment of patients with acute ischemic stroke; findings from a single centre follow up study in real-life settings.
    George M; Baby N; Paul R; Zabeer M; Thomas C
    J Clin Neurosci; 2021 Sep; 91():299-305. PubMed ID: 34373043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tenecteplase Versus Alteplase Between 3 and 4.5 Hours in Low National Institutes of Health Stroke Scale.
    Rønning OM; Logallo N; Thommessen B; Tobro H; Novotny V; Kvistad CE; Aamodt AH; Næss H; Waje-Andreassen U; Thomassen L
    Stroke; 2019 Feb; 50(2):498-500. PubMed ID: 30602354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tenecteplase versus alteplase for management of acute ischemic stroke: a pairwise and network meta-analysis of randomized clinical trials.
    Kheiri B; Osman M; Abdalla A; Haykal T; Ahmed S; Hassan M; Bachuwa G; Al Qasmi M; Bhatt DL
    J Thromb Thrombolysis; 2018 Nov; 46(4):440-450. PubMed ID: 30117036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trial.
    Bivard A; Zhao H; Churilov L; Campbell BCV; Coote S; Yassi N; Yan B; Valente M; Sharobeam A; Balabanski AH; Dos Santos A; Ng JL; Yogendrakumar V; Ng F; Langenberg F; Easton D; Warwick A; Mackey E; MacDonald A; Sharma G; Stephenson M; Smith K; Anderson D; Choi P; Thijs V; Ma H; Cloud GC; Wijeratne T; Olenko L; Italiano D; Davis SM; Donnan GA; Parsons MW;
    Lancet Neurol; 2022 Jun; 21(6):520-527. PubMed ID: 35525251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tenecteplase versus alteplase after acute ischemic stroke at high age.
    Thommessen B; Næss H; Logallo N; Kvistad CE; Waje-Andreassen U; Ihle-Hansen H; Ihle-Hansen H; Thomassen L; Morten Rønning O
    Int J Stroke; 2021 Apr; 16(3):295-299. PubMed ID: 32631157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tenecteplase vs. Alteplase for Intravenous Thrombolytic Therapy of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Shen Z; Bao N; Tang M; Yang Y; Li J; Liu W; Jiang G
    Neurol Ther; 2023 Oct; 12(5):1553-1572. PubMed ID: 37552459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tenecteplase versus alteplase for the treatment of acute ischemic stroke: a meta-analysis of randomized controlled trials.
    Huang J; Zheng H; Zhu X; Zhang K; Ping X
    Ann Med; 2024 Dec; 56(1):2320285. PubMed ID: 38442293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials.
    Xu N; Chen Z; Zhao C; Xue T; Wu X; Sun X; Wang Z
    Drug Des Devel Ther; 2018; 12():2071-2084. PubMed ID: 30013325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.